BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 898501)

  • 1. Immunotherapeutic effect of tumor necrosis in situ.
    Neel HB; Ritts RE
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(2):285-90. PubMed ID: 898501
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation.
    Neel HB; Ketcham AS; Hammond WG
    Laryngoscope; 1973 Mar; 83(3):376-87. PubMed ID: 4690029
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant preoperative and postoperative immunochemotherapy for mammary adenocarcinoma in rats.
    Sparks FC; O'Connell TX; Lee YT
    Surg Forum; 1973; 24():118-21. PubMed ID: 4618633
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapeutic effect of tumor necrosis after cryosurgery, electrocoagulation, and ligation.
    Neel HB; Ritts RE
    J Surg Oncol; 1979; 11(1):45-52. PubMed ID: 431082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor.
    Sabel MS; Arora A; Su G; Chang AE
    Cryobiology; 2006 Dec; 53(3):360-6. PubMed ID: 16973145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunization against human choriogonadotropin on the growth of transplanted Lewis lung carcinoma and spontaneous mammary adenocarcinoma in mice.
    Acevedo HF; Raikow RB; Powell JE; Stevens VC
    Cancer Detect Prev Suppl; 1987; 1():477-86. PubMed ID: 3480061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of tumor immunity after complete excision, cryonecrosis, and in the presence of persistent tumor.
    Neel HB; Ketcham AS; Hammond WG
    Surg Forum; 1970; 21():120-2. PubMed ID: 5514704
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-specific transplantation immunity after cryosurgery.
    Myers RS; Hammond WG; Ketcham AS
    J Surg Oncol; 1969; 1(3):241-6. PubMed ID: 5406367
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced cures of spontaneous murine mammary carcinomas with surgery and five-compound combination chemotherapy, and their immunotherapeutic interrelationship.
    Fugmann RA; Martin DS; Hayworth PE; Stolfi RL
    Cancer Res; 1970 Jul; 30(7):1931-6. PubMed ID: 5456078
    [No Abstract]   [Full Text] [Related]  

  • 11. Adoptive immunotherapy of murine mammary carcinoma using broadly cytotoxic cloned T lymphocytes.
    Salup RR; Toth JA; Hiserodt JC; Wolmark N
    Prog Clin Biol Res; 1987; 244():39-48. PubMed ID: 2958875
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer.
    Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
    Int J Cancer; 1974 Mar; 13(3):389-403. PubMed ID: 4822108
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating tumor antigens versus immune serum factors in depressed concomitant immunity.
    Vaage J
    Cancer Res; 1974 Nov; 34(11):2979-83. PubMed ID: 4425091
    [No Abstract]   [Full Text] [Related]  

  • 16. Host response to premalignant mammary tissues.
    Slemmer G
    Natl Cancer Inst Monogr; 1972 Dec; 35():57-71. PubMed ID: 4659058
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor effect of electrochemical therapy on transplantable mouse cancers.
    Wójcicki M; Droździk M; Olewniczak S; Opolski A; Wietrzyk J; Radzikowski C; Kaczmarek B; Wrzesiński M; Romanowski M; Kamiński M; Zieliński S
    Med Sci Monit; 2000; 6(3):498-502. PubMed ID: 11208360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the effect of irradiated tumor tissue with that of irradiated tumor cells in active specific immunotherapy].
    Ogawa Y; Maeda T; Yoshida S; Yamamoto Y; Morita M; Ogawa Y; Hiratsuka J; Imanaka K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1181-8. PubMed ID: 6663171
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
    Simmons RL; Rios A
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.